Article Type
Article
Changed
Thu, 01/10/2019 - 12:35
Display Headline
Clindamycin Phosphate 1.2%––Benzoyl Peroxide (5% or 2.5%) Plus Tazarotene Cream 0.1% for the Treatment of Acne
Author(s)
Dhawan SS
Gwazdauskas J
Article PDF
091020099.pdf
Issue
Cutis - 91(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
99-104
Legacy Keywords
combination therapies for acne treatment, adjuvant medications for acne, acne treatment, topical acne treatment, acne vulgaris, tolerability of topical acne treatments
Sections
Original Research
Author(s)
Dhawan SS
Gwazdauskas J
Author(s)
Dhawan SS
Gwazdauskas J
Article PDF
091020099.pdf
Article PDF
091020099.pdf
Issue
Cutis - 91(2)
Issue
Cutis - 91(2)
Page Number
99-104
Page Number
99-104
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Clindamycin Phosphate 1.2%––Benzoyl Peroxide (5% or 2.5%) Plus Tazarotene Cream 0.1% for the Treatment of Acne
Display Headline
Clindamycin Phosphate 1.2%––Benzoyl Peroxide (5% or 2.5%) Plus Tazarotene Cream 0.1% for the Treatment of Acne
Legacy Keywords
combination therapies for acne treatment, adjuvant medications for acne, acne treatment, topical acne treatment, acne vulgaris, tolerability of topical acne treatments
Legacy Keywords
combination therapies for acne treatment, adjuvant medications for acne, acne treatment, topical acne treatment, acne vulgaris, tolerability of topical acne treatments
Sections
Original Research
Disallow All Ads
Alternative CME
Article PDF Media